Stocks and Investing
Stocks and Investing
Thu, November 19, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Berens Maintained (BGNE) at Buy with Increased Target to $327 on, Nov 19th, 2020
Andrew Berens of SVB Leerink, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $240 to $327 on, Nov 19th, 2020.
Andrew has made no other calls on BGNE in the last 4 months.
There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $310 on, Wednesday, November 11th, 2020
- Tyler Van Buren of "Piper Sandler" Downgraded from Hold to Sell and Held Target at $185 on, Friday, November 6th, 2020
Contributing Sources